Liver Metastases in Prostate Carcinoma Represent a Relatively Aggressive Subtype Refractory to Hormonal Therapy and Short-Duration Response to Docetaxel Monotherapy.
about
Liver Metastases in Prostate Carcinoma Represent a Relatively Aggressive Subtype Refractory to Hormonal Therapy and Short-Duration Response to Docetaxel Monotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Liver Metastases in Prostate C ...... onse to Docetaxel Monotherapy.
@en
Liver Metastases in Prostate C ...... onse to Docetaxel Monotherapy.
@nl
type
label
Liver Metastases in Prostate C ...... onse to Docetaxel Monotherapy.
@en
Liver Metastases in Prostate C ...... onse to Docetaxel Monotherapy.
@nl
prefLabel
Liver Metastases in Prostate C ...... onse to Docetaxel Monotherapy.
@en
Liver Metastases in Prostate C ...... onse to Docetaxel Monotherapy.
@nl
P2093
P2860
P356
P1476
Liver Metastases in Prostate C ...... onse to Docetaxel Monotherapy.
@en
P2093
Arsh Singh
Dong-Sung Kim
Frederick Gulmi
Jen C Wang
Naga K S Cheedella
Shams A Shakil
P2860
P304
P356
10.14740/WJON903W
P577
2015-02-14T00:00:00Z